What you need to know A 58 year old man presents to his general practitioner (GP) to discuss recent blood test results after ...

Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...

Grade 1 fatty liver, where liver cells contain a surplus of fat, roughly five to ten percent above normal, usually goes unnoticed because it rarely produces symptoms. However, left untreated, it can ...

The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' gene therapy Elevidys ...

Elevidys now carries a black box warning for acute liver injury and failure, limiting its use to ambulatory patients aged four and older. The FDA's actions follow fatal liver failure reports in ...

This trend is highlighting the increasing role of lifestyle, diet, and metabolic health in affecting the liver.

The therapeutic landscape for hepatocellular carcinoma (HCC) has been revolutionized by the advent of molecular targeted therapies and immune ...

Sarepta must also run a post-marketing study for Elevidys to better assess the risk of serious liver injury in patients dosed ...

After patient deaths FDA adds boxed warning and limits Elevidys use to ambulatory Duchenne muscular dystrophy patients.

By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...

The FDA is requiring the manufacturer to conduct a postmarketing observational study to further assess the risk of serious liver injury. The study will enroll approximately 200 patients with DMD and ...

Prime Medicine, Inc. ( PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease November 12, 2025 8:00 AM EST ...